The FluoroSpark Chip

A Sample-to-Answer Microfluidic Device for Disease Diagnostics at the Point-of-Care


As Featured On:


Powerful Autonomous Tech

The FluoroSpark Chip features cost-effective solutions to existing technologies with PCB-powered enhancements that control pumping and heating. The entire sample-to-answer process is self-contained and powered by contained sources.



The device takes a an unprocessed sample such as blood or urine, performs sample preparation, isolates and captures nucleic acid strands, purifies targets, and amplifies target sequences for disease detection. 


Nucleic Acid Amplification

Isothermal amplification takes place on-chip, minimizing risks of cross-contamination and the need for continuous thermal cycling. Within 30 minutes, specific sequences are targeted by sample reagents and amplified for fluorescent analysis

Our Technology

RNA-based infectious diseases have been sources of large-scale epidemics and pandemics resulting in millions of casualties worldwide. Detection of these biological agents normally involves many lab processes including sample preparation, nucleic acid separation and amplification, and detection. These steps, either performed manually using pipettes or automatedly using bulky and costly instruments, are tedious, expensive, and highly susceptible to cross-contamination. In this project, an integrated and self-contained lab-on-a-chip device was developed for sample-to-answer biological analysis of RNA-based infectious diseases. The device consists of: 1) an acoustic-based micromixer that enhanced target cell lysis and mixing between target RNA and magnetic beads for RNA capture; 2) on-board reagent storage blisters that also serve as pumps and valves; 3) an electrochemical micropump; 4) single-use wax microvalves; 5) a chamber to perform RNA concentration and purification; 6) a chamber to perform RNA isothermal amplification. Acoustic micromixing was optimized to significantly reducing mixing time from 6 hr to 7 sec. The electrochemical pump was successfully demonstrated in a one-pump flow system and characterized to optimize the capture/retention of RNA. Lastly, a battery-powered portable instrument was developed to control the mechanical operation of the device. The integrated, self-contained device successfully performed sample-to-answer genetic analysis of Chlamydia Trachomatis and Mycoplasma Genitalium from human urine samples. This technology demonstrates a potential of integrating the entire genetic diagnostic process into a handheld device, completely independent of external apparatus, for the diagnosis of hundreds of infectious diseases.